Skip to main content

Stryker Corp(SYK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low325.00
Day High334.59
Open:327.99
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
2 Large-Cap Stocks Worth Investigating and 1 We Turn Down
ON
Tipranks
Canaccord Genuity Sticks to Its Buy Rating for Stryker (SYK)
StockStory
2 Profitable Stocks to Target This Week and 1 Facing Headwinds
SE
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Stryker (SYK), Solid Biosciences (SLDB)
Tipranks
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Stryker (SYK) and Genmab (GMAB)
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: IDEAYA Biosciences (IDYA), BioNTech SE (BNTX) and Stryker (SYK)
Tipranks
Stryker (SYK) Receives a Buy from BTIG
GlobeNewswire
Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio
Tipranks
Analysts’ Top Healthcare Picks: Simulations Plus (SLP), Stryker (SYK)
Zacks Investment Research
ISRG Stock Down Nearly 20% YTD: Should You Buy, Hold or Sell?
ISRG Stock Down Nearly 20% YTD: Should You Buy, Hold or Sell?
StockStory
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
SYK
Tipranks
Stryker (SYK) Receives a Hold from Goldman Sachs
Zacks Investment Research
Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation?
Can 13-15% Procedure Growth in 2026 Sustain ISRG's Premium Valuation?
StockStory
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings?
SYK
Motley Fool
This Healthcare Stock Has No Debt and a Near-Monopoly in Its Market
Zacks Investment Research
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
JNJ Q1 MedTech Preview: Key Drivers and China Headwinds to Watch
GlobeNewswire
Stryker to announce financial results for its first quarter of fiscal year 2026
GlobeNewswire
Stryker names Nick Mead Vice President, Investor Relations
StockStory
2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds
VRTX
Tipranks
Stryker Addresses and Contains Recent Cybersecurity Incident
GlobeNewswire
Stryker announces Annual Meeting of Shareholders
Zacks Investment Research
Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
Intuitive Surgical vs. Stryker: Which Surgical Tech Stock Leads?
Tipranks
DBS Remains a Buy on Stryker (SYK)
StockStory
1 Oversold Stock Primed to Rebound and 2 We Question
ARHS
Zacks Investment Research
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Here's Why You Should Hold Stryker Stock in Your Portfolio for Now
Tipranks
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Stryker (SYK) and Esperion (ESPR)
StockStory
Stocks making big moves yesterday: El Pollo Loco, Stryker, Dollar Tree, Coinbase, and Distribution Solutions
LOCO
StockStory
Stryker (SYK) Stock Is Up, What You Need To Know
SYK
Motley Fool
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment
Motley Fool
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Stryker (SYK) and Elutia (ELUT)

Profile

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.